Minerva Neurosciences Inc (NERV) is higher by Thursday morning, with the stock rising 2.96% in pre-market trading to 1.74. NERV's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, NERV ranks higher than 2% of stocks. Minerva Neurosciences Inc has fallen 23.53% over the past month, closing at $2.02 on July 15. During this period of time, the stock fell as low as $1.59 and as high as $2.09. NERV has an average analyst recommendation of Buy. The company has an average price target of $6.50.
NERV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NERV!